Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis

Arthritis and Rheumatism

Volumn 60, Issue 3, 2009, Pages 878-882

  Herrick, Ariane L ^a,b   Roberts, Christopher ^a   Tracey, Andrew ^a   Silman, Alan ^a   Anderson, Marina ^c   Goodfield, Mark ^d   McHugh, Neil ^e   Muir, Lindsay ^b   Denton, Christopher P ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

^e ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^f ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGITAL IMAGING; FINGER INJURY; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; KAPPA STATISTICS; PRIORITY JOURNAL; RHEUMATOLOGY; SYSTEMIC SCLEROSIS;

HUMANS; INTERNET; OBSERVER VARIATION; RHEUMATOLOGY; SCLERODERMA, SYSTEMIC; SKIN ULCER;

EID: 61649095440     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24333     Document Type: Article

References (9)

1. Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 2001;60:585-91.
2. Nihtyanova SI, Brough GM, Black CM, Denton CP. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 2008;67:120-3.
3. Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, et al, for the RAPIDS-1 Study Group. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004;50:3985-93.
4. Gliddon AE, Dore CJ, Black CM, McHugh N, Moots R, Denton CP, et al. Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. Arthritis Rheum 2007;56:3837-46.
5. Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum 2002;46:2410-20.
6. Roberts C, McNamee R. A matrix of kappa-type coefficients to assess the reliability of nominal scales. Stat Med 1998;17:471-88.
7. Roberts C. Modelling patterns of agreement for nominal scales. Stat Med 2008;27:810-30.
8. Stata statistical software: release 9.0. College Station (TX): Stata Corporation; 2005.
9. Sari-Kouzel H, Hutchinson CE, Middleton A, Webb F, Moore T, Griffin K, et al. Foot problems in patients with systemic sclerosis. Rheumatology (Oxford) 2001;40:410-3.